Burning Rock Biotech Limited (BNR)

R&D to Revenue

30.86%

Fiscal year · Period ending:

BNR logo

BNR R&D to Revenue

Latest reported30.86%
BNR FY R&D/Revenue (44.10% → 30.86%)
High-resolution chart · PNG

BNR r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Burning Rock Biotech Limited R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
30.8569%
45.033%
64.5689%
74.9005%
72.4327%
61.3952%
41.1172%
50.4144%
44.098%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.